Loading...
Market
What will be the outcome of the first clinical trial phase for the new lupus treatment by July 11, 2025?
2
Resolution / Starting Odds
Successful completion of Phase 1 • 25%
Partial success in Phase 1 • 25%
Failure in Phase 1 • 25%
No results announced • 25%
Clinical trial reports or announcements from the research team
Story
Discovery of Immune Defect by Chicago Researchers Could Lead to Lupus Cure
Jul 11, 2024, 01:00 AM
Researchers have identified a molecular defect in the immune system that may be the root cause of lupus, a life-threatening condition. This discovery, described as a 'molecular switch' or 'naturally occurring seesaw,' could potentially reverse the harmful immune response and lead to new treatments or a cure for the autoimmune disorder. The breakthrough was made by scientists from Northwestern Medicine, Brigham and Women's Hospital, and Chicago researchers, pointing to a future where the immune cells driving lupus damage could be turned into beneficial cells, thereby saving tissue and preventing the immune system from attacking the body.
View original story
Similar markets
Completed with positive results • 25%
Completed with negative results • 25%
Not completed • 25%
Unknown/Other • 25%
Positive results • 25%
Negative results • 25%
Inconclusive results • 25%
Trial discontinued • 25%
Positive results • 25%
Negative results • 25%
Inconclusive results • 25%
Trial halted • 25%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Yes • 50%
No • 50%
Positive results • 25%
Negative results • 25%
Inconclusive results • 25%
Trial not completed • 25%
Complete Response • 25%
Partial Response • 25%
Stable Disease • 25%
Progressive Disease • 25%
Positive results • 25%
Negative results • 25%
Mixed results • 25%
No results announced • 25%
Clinical hold • 25%
No action • 25%
Request for additional data • 25%
Other • 25%